Artwork
iconShare
 
Manage episode 492479348 series 58
Content provided by ABC Radio and ABC listen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ABC Radio and ABC listen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Synthetic biologists are hard at work developing artificial biological molecules as the first step toward developing a mirror cell that would be immune from infection. If they're successful, it could transform the world of medicine. But while the potential of mirror life is great, so too are the risks. There are warnings of a catastrophic impact if the cells can't be controlled. And that's prompted calls for a moratorium on the research.

Guests

Associate Professor Kate Adamala — Synthetic biologist and professor of genetics, University of Minnesota

Professor Andrew Ellington — Center for Systems and Synthetic Biology, University of Texas at Austin

Professor Heather Douglas — Department of Philosophy, Michigan State University

Ajay Kshatriya — CEO Aizen Therapeutics

  continue reading

1063 episodes